HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Illness absences among beryllium sensitized workers.

AbstractOBJECTIVES:
This study examined absence rates among US Department of Energy workers who had beryllium sensitization (BeS) or were diagnosed with chronic beryllium disease (CBD) compared with those of other workers.
METHODS:
We used the lymphocyte proliferation test to determine beryllium sensitivity. In addition, we applied multivariable logistic regression to compare absences from 2002 to 2011 between workers with BeS or CBD to those without, and survival analysis to compare time to first absence by beryllium sensitization status. Finally, we examined beryllium status by occupational group. Results. Fewer than 3% of the 19,305 workers were BeS, and workers with BeS or CBD had more total absences (odds ratio [OR] = 1.31; 95% confidence interval [CI] = 1.18, 1.46) and respiratory absences (OR = 1.51; 95% CI = 1.24, 1.84) than did other workers. Time to first absence for all causes and for respiratory conditions occurred earlier for workers with BeS or CBD than for other workers. Line operators and crafts personnel were at increased risk for BeS or CBD. Conclusions. Although not considered "diseased," workers with BeS have higher absenteeism compared with nonsensitized workers.
AuthorsJanice P Watkins, Elizabeth D Ellis, David J Girardi, Donna L Cragle, Bonnie S Richter
JournalAmerican journal of public health (Am J Public Health) Vol. 104 Issue 11 Pg. e165-9 (Nov 2014) ISSN: 1541-0048 [Electronic] United States
PMID25211750 (Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Beryllium
Topics
  • Absenteeism
  • Adult
  • Berylliosis (epidemiology)
  • Beryllium (adverse effects)
  • Female
  • Humans
  • Logistic Models
  • Male
  • Middle Aged
  • Occupational Exposure (adverse effects)
  • Sick Leave (statistics & numerical data)
  • Survival Analysis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: